Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder

Neuropsychopharmacology

Volumn 15, Issue 1, 1996, Pages 7-15

  Schreiber, Wolfgang ^a,b   Lauer, Christoph Johannes ^a   Krumrey, Klaus ^a   Holsboer, Florian ^a   Krieg, Jürgen Christian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

ACTH; Cortisol; Dexamethasone corticotropin releasing hormone (DEX CRH) challenge test; Major depression; Panic disorder

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN TEST; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL;

EID: 0030200878     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00146-5     Document Type: Article

References (63)

1. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, ed. 3, rev. Washington, DC, American Psychiatric Association
2. Barden N, Reul JMHM, Holsboer F (1995): Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci 18:6-11
3. Blouin J, Spindler E, Perez E, Blouin A, Hotz S, Hakkaku J (1992): The role of stress in interpreting the dexamethasone suppression test. Can J Psychiatry 37:724-727
4. Bourgeois M (1993): Stress, anxiété, panique. L'attaque de panique et le trouble panique. Un nouveau concept psychiatrique. Encéphale 19(Spec. No. 1):187-191
5. Brambilla F, Bellodi L, Perna G, Battaglia M, Sciuto G, Diaferia G, Petraglia F, Panerai A, Sacerdote P (1992): Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology 26:12-22
6. Breier A, Albus M, Pickar D, Zahn TP, Wolkowitz OM, Paul SM (1987): Controllable and uncontrollable stress in humans: Alterations in mood and neuroendocrine and psychophysiological function. Am J Psychiatry 144: 1419-1425
7. Britton DR, Koob GF, Rivier J, Vale W (1982): Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci 31:363-367
8. Bronisch T (1990): Survey of recent empirical studies on the classification, pathogenesis and therapy of anxiety disturbances. Fortschr Neurol Psychiatr 58:98-113
9. Butler PD, Weiss JM, Stout JC, Nemeroff CB (1990): Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 10:176-183
10. Cameron OG, Nesse RM (1988): Systemic hormonal and physiological abnormalities in anxiety disorders. Psychoneuroendocrinology 13:287-307
11. Chappel PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C, Nemeroff CB (1986): Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6:2908-2914
12. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M (1993): Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 50:294-305
13. Cole BJ, Koob GF (1988): Propanolol antagonizes the enhanced conditioned fear produced by corticotropin releasing factor. J Pharmacol Exp Ther 47:902-910
14. Coryell W, Noyes R, Reich G (1991): The prognostic significance of HPA-axis disturbance in panic disorder: A three-year follow-up. Biol Psychiatry 29:96-102
15. Dahl R, Puig-Antich J, Ryan N, Nelson B, Novacenko H, Twomey J, Williamson D, Goetz R, Ambrosini PJ (1989): Cortisol secretion in adolescents with major depressive disorder. Acta Psychiatr Scand 80:18-26
16. Den Boer JA, Westenberg HG (1990): Serotonin function in panic disorder: A double blind placebo controlled study with fluvoxamine and ritanserine. Psychopharmacology 102:85-94
17. Dunn AJ, Berridge CW (1990): Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res Rev 15:71-100
18. Dunn AJ, File SE (1987): Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Horm Behav 21:193-202
19. Evans L (1989): Some biological aspects of panic disorders. Int J Clin Pharmacol Res 9:139-145
20. Gold PW (1990): Possible role for corticotropin-releasing hormone in panic disorder. J Psychiatr Res 24(suppl 1):86-87
21. Gorman JM, Liebowitz MR, Fyer AJ, Stein J (1989): A neuroanatomical hypothesis for panic disorder. Am J Psychiatry 146:148-161
22. Hamilton M (1968): Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296
23. Hamilton M (1976): Hamilton Anxiety Scale. In Guy W (ed), ECDEU Assessment Manual for Psychopharmacology. Rockville, MD, National Institute of Mental Health, pp 193-198
24. Heuser IJE, Gotthardt U, Schweiger U, Schmider J, Lammers CH, Dettling M, Holsboer F (1994a): Age-associated changes of pituitary-adrenocortical hormone regulation in humans: Importance of gender. Neurobiol Aging 15:227-231
25. Heuser IJE, Yassouridis A, Holsboer F (1994b): The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders. J Psychiatr Res 28:341-356
26. Holsboer F (1992): The endocrinology of mental disease. In Grossman A (ed), Clinical Endocrinology, Oxford, Blackwell, pp 996-1011
27. Holsboer F (1995): Neuroendocrinology of mood disorders. In Bloom FE, Kupfer DJ (eds), Psychopharmacology. The Fourth Generation of Progress. New York, Raven Press, pp 957-969
28. Holsboer F, von Bardeleben U, Buller R, Heuser I, Steiger A (1987): Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Horm Metab Res 16:80-88
29. Holsboer F, Spengler D, Heuser I (1992): The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog Brain Res 93:385-417
30. Humble M, Wistedt B (1992): Serotonin, panic disorder and agoraphobia: Short-term and long-term efficacy of citalopram in panic disorders. Int Clin Psychopharmacol 6(suppl 5):21-39
31. Kahn RS, van Praag HM (1992): Panic disorder: A biological perspective. Eur Neuropsychopharmacol 2:1-20
32. Kalin NH, Shelton SE, Bardsdale CM (1989): Behavioral and physiologic effects of CRH administered to infant primates undergoing maternal separation. Neuropsychopharmacology 2:97-104
33. Kathol RG, Anton R, Noyes R, Gehris T (1989): Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder. Biol Psychiatry 25:873-878
34. Kellner M, Herzog L, Yassouridis A, Holsboer F, Wiedemann K (1995): Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic. Am J Psychiatry 152:1365-1367
35. Kopp MS, Arato M, Magyar I, Buza Q (1989): Basal adrenocortical activity and DST in electrodermally differentiated subgroups of panic patients. Int J Psychophysiol 7:77-83
36. Kuboki T, Suematsu H (1992): Panic disorder. Nippon Rinsho 50:2773-2782
37. Larson MC, Gunnar MR, Hertsgaard C (1991): The effects of morning naps, car trips and maternal separation of adrenocortical activity in human infants. Child Dev 62:362-372
38. 1A receptor responsivity in anxiety disorders and depression. Prog Neuro Psychopharmacol Biol Psychiatry 15:723-733
39. Lopez AL, Kathol RG, Noyes R (1990): Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder. Psychoneuroendocrinology 15:23-28
40. Nisticò G, Nappi G (1993): Locus coeruleus, an integrative station involved in the control of several vital functions. Funct Neurol 8:5-25
41. Nutt D, Lawson C (1992): Panic attacks. A neurochemical overview of models and mechanisms. Br J Psychiatry 160:165-178
42. Owens MJ, Bissette G, Nemeroff CB (1989): Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain. Synapse 4:196-202
43. Plotsky PM, Owens MJ, Nemeroff CB (1995): Neuropeptide alterations in mood disorders. In Bloom FE, Kupfer DJ (eds), Psychopharmacology. The Fourth Generation of Progress. New York, Raven Press, pp 971-981
44. Pich EM, Heinrichs SC, Rivier C, Miczek KA, Fisher DA, Koob GF (1993): Blockade of pituitary-adrenal axis activation induced by peripheral immunoneutralization of corticotropin-releasing factor does not affect the behavioral response to social defeat stress in rats. Psychoneuroendocrinology 18:495-507
45. Raadsheer FC, Hoogendijk WJG, Stam FC, Tilders FJH, Swaab DF (1994): Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60:436-444
46. Rapaport MH, Risch SC, Golshan S, Gillin JC (1989): Neuroendocrine effects of ovine corticotropin-releasing hormone in panic disorder patients. Biol Psychiatry 26:344-348
47. Reul JMHM, Stec I, Söder M, Holsboer F (1993): Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133:312-320
48. Roy-Byrne PP (1992): Integrated treatment of panic disorder. Am J Med 92(1A):49S-54S
49. Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW (1986): The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 143:896-899
50. Roy-Byrne PP, Cowley DS, Hommer D, Ritchie J, Greenblatt D, Nemeroff C (1991): Neuroendocrine effects of diazepam in panic and generalized anxiety disorders. Biol Psychiatry 30:73-80
51. Rubinow DR, Post RM, Gold PW, Ballenger JC, Reichlin S (1985): Effects of carbamazepine on cerebrospinal somatostatin. Psychopharmacology 85:210-213
52. Sive WJ, Hattingh J (1991): The measurement of psychophysiological reactions of pilots to a stresser in a flight simulator. Aviat Space Environ Med 62:831-836
53. Skutella T, Criswell H, Moy S, Probst JC, Breese GR, Jirikowsky GF, Holsboer F (1994): Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat. NeuroReport 5:2181-2185
54. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983): Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology 36: 165-186
55. Swerdlow NR, Geyer MA, Vale W, Koob GF (1986): Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide. Psychopharmacology 88:147-152
56. Valentino RJ (1989): Corticotropin-releasing factor putative neurotransmitter in the noradrenergic nucleus locus coeruleus. Psychol Bull 25(suppl 3):306-311
57. Valentino RJ, Foote SL, Aston-Jones G (1983): CRF activates noradrenergic neurons of the locus coeruleus. Brain Res 270:363-367
58. Valentino RJ, Page ME, Curtis AL (1991): Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of CRF. Brain Res 555:25-34
59. van Gool D, Igodt P, de Cuyper H (1992): Mode of action of the triazolo-benzodiazepines in the treatment of panic attacks: A hypothesis. Eur Neuropsychopharmacol 2: 433-441
60. Vecsei L, Widerlöv E (1988): Brain and CSF somatostatin concentrations in patients with psychiatric or neurological illness: An overview. Acta Psychiatr Scand 78:657-667
61. von Bardeleben U, Holsboer F (1989): Cortisol response to a combined dexamethasone-human corticotropin-releasing hormone challenge in patients with depression. J Neuroendocrinol 1:485-488
62. von Bardeleben U, Holsboer F (1991): Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone. Biol Psychiatry 29:1042-1050
63. Wittchen HU, Zaudig M, Schramm E, Spengler P, Mombour W, Klug J, Horn R (1990): Strukturiertes Klinisches Interview für DSM-III-R. Weinheim, Beltz-Verlag